Andrew T. Millican

710 citations

15 papers · 538 indexed · h-index 12

Co-authors: David Parker Kenneth Millar Nigel R. A. Beeley Michael A. W. Eaton Byron A. Boyce Karl J. Jankowski Alice Harrison J. Richard Morphy
Topics: Monoclonal and Polyclonal Antibodies Research (6 papers)Chemical Synthesis and Analysis (5 papers)Radiopharmaceutical Chemistry and Applications (5 papers)
Cited by: Radiology, Nuclear Medicine and Imaging Oncology Cancer Research
Journals: Tetrahedron Journal of Pharmaceutical Sciences Synthesis
Partner nations: United Kingdom Japan United States

In The Last Decade

Andrew T. Millican

15 papers receiving 484 citations

Peers

Countries citing papers authored by Andrew T. Millican

Since Specialization

Citations

This map shows the geographic impact of Andrew T. Millican's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew T. Millican with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew T. Millican more than expected).

Fields of papers citing papers by Andrew T. Millican

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew T. Millican. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew T. Millican. The network helps show where Andrew T. Millican may publish in the future.

Co-authorship network of co-authors of Andrew T. Millican

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew T. Millican. A scholar is included among the top collaborators of Andrew T. Millican based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew T. Millican. Andrew T. Millican is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Conversion of highly malignant colon cancer from an aggressive to a controlled disease by oral administration of a metalloproteinase inhibitor 1997 ·Clinical & Experimental Metastasis ·(unknown),Xiaoen Wang,N. Willmott,Surinder K. Chander,Simon Tickle,Andrew Docherty,Andrew Mountain,Andrew T. Millican,Richard Morphy,John Porter,(unknown),Tetsuro Kubota,A. R. Moossa,(unknown)	48
2	An in Vivo Model for Screening Peptidomimetic Inhibitors of Gelatinase A 1995 ·Journal of Pharmaceutical Sciences ·Surinder K. Chander,Pari Antoniw,Nigel R. A. Beeley,Byron A. Boyce,Thomas Crabbe,Andrew Docherty,J. C. Leonard,Barbara Mason,Kenneth Millar,Andrew T. Millican,Richard Morphy,Andrew Mountain,James P. O’Connell,John Porter,N. Willmott	10
3	Potent and selective inhibitors of gelatinase-a 1. hydroxamic acid derivatives 1994 ·Bioorganic & Medicinal Chemistry Letters ·John Porter,Nigel R. A. Beeley,Byron A. Boyce,Barbara Mason,Andrew T. Millican,Kenneth Millar,J. C. Leonard,J. Richard Morphy,James P. O’Connell	33
4	Potent and selective inhibitors of gelatinase-A 2. carboxylic and phosphonic acid derivatives 1994 ·Bioorganic & Medicinal Chemistry Letters ·J. Richard Morphy,Nigel R. A. Beeley,Byron A. Boyce,J. C. Leonard,Barbara Mason,Andrew T. Millican,Kenneth Millar,James P. O’Connell,John Porter	31
5	ChemInform Abstract: Synthesis of New Macrocyclic Amino‐Phosphinic Acid Complexing Agents and Their C‐ and P‐Functionalized Derivatives for Protein Linkage. 1992 ·ChemInform ·(unknown),(unknown),Karl J. Jankowski,David Parker,(unknown),Byron A. Boyce,Nigel R. A. Beeley,(unknown),Andrew T. Millican	2
6	Synthesis of New Macrocyclic Amino-Phosphinic Acid Complexing Agents and TheirC-andP-Functionalised Derivatives for Protein Linkage 1992 ·Synthesis ·(unknown),(unknown),Karl J. Jankowski,David Parker,(unknown),Byron A. Boyce,Nigel R. A. Beeley,Kenneth Millar,Andrew T. Millican	27
7	The in vivo release of 90Y from cyclic and acyclic ligand-antibody conjugates 1991 ·International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology ·A. Harrison,(unknown),David Parker,Karl J. Jankowski,J. P. Cox,Andrew S. Craig,J. M. Sansom,Nigel R. A. Beeley,Rich Boyce,L Chaplin,Michael A. W. Eaton,(unknown),Kenneth Millar,Andrew T. Millican,(unknown),(unknown),(unknown),Alison Turner	62
8	The synthesis of novel bifunctional linker molecules 1991 ·Tetrahedron ·(unknown),John Mann,(unknown),Rikki Alexander,Michael A. W. Eaton,Kenneth Millar,Andrew T. Millican	6
9	Synthesis of C- and N-functionalised derivatives of 1,4,7-triazacyclononane-1,4,7-triyltriacetic acid (NOTA), 1,4,7,10-tetra-azacyclododecane-1,4,7,10-tetrayltetra-acetic acid (DOTA), and diethylenenetriaminepenta-acetic acid (DTPA): bifunctional complexing agents for the derivatisation of antibodies 1990 ·Journal of the Chemical Society Perkin Transactions 1 ·J. P. Cox,Andrew S. Craig,I. M. HELPS,Karl J. Jankowski,David Parker,Michael A. W. Eaton,Andrew T. Millican,Kenneth Millar,Nigel R. A. Beeley,Byron A. Boyce	66
10	Site-specific attachment to recombinant antibodies via introduced surface cysteine residues 1990 ·Protein Engineering Design and Selection ·A. Bruce Lyons,David J. King,Raymond J. Owens,Geoffrey Yarranton,Andrew T. Millican,Nigel Whittle,John R. Adair	53
11	Towards tumour targeting with copper-radiolabelled macrocycle–antibody conjugates: synthesis, antibody linkage, and complexation behaviour 1990 ·Journal of the Chemical Society Perkin Transactions 2 ·J. Richard Morphy,David Parker,Ritu Kataky,Michael A. W. Eaton,Andrew T. Millican,Rikki Alexander,Alice Harrison,(unknown)	31
12	Synthesis of a kinetically stable yttrium-90 labelled macrocycle–antibody conjugate 1989 ·Journal of the Chemical Society Chemical Communications ·J. P. Cox,Karl J. Jankowski,Ritu Kataky,David Parker,Nigel R. A. Beeley,Byron A. Boyce,Michael A. W. Eaton,Kenneth Millar,Andrew T. Millican,Alice Harrison,(unknown)	65
13	Towards tumour imaging with indium-111 labelled macrocycle–antibody conjugates 1989 ·Journal of the Chemical Society Chemical Communications ·Andrew S. Craig,I. M. HELPS,Karl J. Jankowski,David Parker,Nigel R. A. Beeley,Byron A. Boyce,Michael A. W. Eaton,Andrew T. Millican,Kenneth Millar,(unknown),(unknown),Alice Harrison,(unknown)	40
14	Towards tumour targeting with copper-radiolabelled macrocycle–antibody conjugates 1989 ·Journal of the Chemical Society Chemical Communications ·J. Richard Morphy,David Parker,Ritu Kataky,Alice Harrison,Michael A. W. Eaton,Andrew T. Millican,(unknown),(unknown)	24
15	Antibody labelling with functionalised cyclam macrocycles 1988 ·Journal of the Chemical Society Chemical Communications ·J. Richard Morphy,David Parker,Rikki Alexander,(unknown),(unknown),Michael A. W. Eaton,Alice Harrison,Andrew T. Millican,(unknown),(unknown),Richard C. Titmas,(unknown)	40

About Andrew T. Millican

Andrew T. Millican is a scholar working on Radiology, Nuclear Medicine and Imaging, Biotechnology and Organic Chemistry, having authored 15 papers that have together received 538 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (6 papers), Chemical Synthesis and Analysis (5 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (281 citations), Oncology (223 citations) and Cancer Research (91 citations). Andrew T. Millican has collaborated with scholars based in United Kingdom, Japan and United States. Frequent co-authors include David Parker, Kenneth Millar, Nigel R. A. Beeley, Michael A. W. Eaton, Byron A. Boyce, Karl J. Jankowski, Alice Harrison, J. Richard Morphy, J. P. Cox and Ritu Kataky. Their work appears in journals such as Tetrahedron, Journal of Pharmaceutical Sciences and Synthesis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact